Successful treatment of post-transplant relapsed adult T cell leukemia after cord blood transplantation with low-dose, short-term lenalidomide

Leuk Lymphoma. 2018 Oct;59(10):2474-2477. doi: 10.1080/10428194.2018.1427859. Epub 2018 Jan 31.

Affiliations

¹ a Department of Internal Medicine, Division of Hematology, Respiratory Medicine and Oncology, Faculty of Medicine , Saga University , Saga , Japan.
² b Department of Transfusion Medicine , Saga University Hospital , Saga , Japan.
³ c Department of Pathology and Microbiology, Faculty of Medicine , Saga University , Saga , Japan.

PMID: 29382244
DOI: 10.1080/10428194.2018.1427859

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cord Blood Stem Cell Transplantation*
Humans
Immunologic Factors / therapeutic use*
Lenalidomide / therapeutic use*
Leukemia-Lymphoma, Adult T-Cell / immunology
Leukemia-Lymphoma, Adult T-Cell / pathology
Leukemia-Lymphoma, Adult T-Cell / therapy*
Male
Middle Aged
Neoplasm Recurrence, Local / drug therapy*
Neoplasm Recurrence, Local / immunology
Neoplasm Recurrence, Local / pathology
Treatment Outcome

Substances

Immunologic Factors
Lenalidomide